Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer.
about
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancerMolecular mechanisms of ETS transcription factor-mediated tumorigenesisA promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers.Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cellsExpression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells.BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.The ETS family of oncogenic transcription factors in solid tumours.Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy.Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells.Ets transcription factors in intestinal morphogenesis, homeostasis and disease.MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.Misexpression of ELF5 disrupts lung branching and inhibits epithelial differentiation.ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.Gene silencing associated with SWI/SNF complex loss during NSCLC development.Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells.The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.ETS1 regulates NKX3.1 5' promoter activity and expression in prostate cancer cells.RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites.Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression.ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
P2860
Q21091136-1A85EC10-EFDC-4C21-9FE8-CD7ECD1F9DE3Q26829833-588AC60C-A745-434A-8BCC-3A1468EEDC9AQ33766602-A95D06BE-BF12-4B79-A143-3878BEBE7D17Q33803406-A8847EAB-B094-4A74-95E2-EF5B47326159Q34170879-00234ECA-29F7-435C-A406-B2B6AD36BB62Q34490196-08B7B0EC-97C6-4022-9D9E-07F1B791C232Q34518491-EA9A9AFB-1040-412B-8656-9442DF710C05Q34555986-D0C2084D-C018-441A-9FA0-D808A6C0FD78Q35493982-D58C736F-727E-44A0-86F4-E1BA230D7A5CQ35581976-9423FD3D-2307-4D89-A699-C1DC345F547DQ35823413-BD0CD156-E52A-4EA6-A905-E205838F7794Q37234973-44CFC6EF-B587-413B-8CC7-F235B8C3A5DCQ37266336-7B5F514D-9237-431B-AF4A-A27978C29FC4Q37452209-A7341220-ABB7-4352-B908-9FEB0DB693D7Q37465999-2E224E77-7031-4E07-92FC-022692866C1AQ37628964-11FFF480-45EB-4351-B215-A5276CDF27C9Q37718285-625F805C-AEDC-4ABE-B640-62624F58E6C3Q38290184-F2E96E5A-DF9C-4E8D-B069-F5ED97548574Q38727369-7AF8E21D-8CDD-429A-B323-7A29FA0F32A7Q38794787-840CFFF4-1022-45A6-8D94-8D53E7363ED0Q38844895-1EBC3034-9D5E-4E3C-89E1-9C53793A7E4EQ39397231-9D6877B0-F2EB-4EA3-AA71-BC54663E76CDQ39655762-3A3BEE59-C20D-4B18-9CF2-78F203876946Q41879970-7A52B5BD-443E-4193-8134-B82D4B4EE051Q47577817-F749A993-267B-41D7-9DC4-A40184A93043Q58696663-7CA659AD-44D6-4A64-8A11-6EFD7FE42F03
P2860
Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reduced expression and tumor s ...... ctor ESE-3 in prostate cancer.
@en
type
label
Reduced expression and tumor s ...... ctor ESE-3 in prostate cancer.
@en
prefLabel
Reduced expression and tumor s ...... ctor ESE-3 in prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Reduced expression and tumor s ...... ctor ESE-3 in prostate cancer.
@en
P2093
Albertini V
Carbone GM
Catapano CV
Mello-Grand M
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210953
P407
P577
2007-11-26T00:00:00Z
P5875
P6179
1019150047